A50 Stock Overview
An investment holding company, provides healthcare services for women and children in Singapore and Malaysia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Thomson Medical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.051 |
| 52 Week High | S$0.062 |
| 52 Week Low | S$0.047 |
| Beta | 0.77 |
| 11 Month Change | 2.00% |
| 3 Month Change | -1.92% |
| 1 Year Change | -15.00% |
| 33 Year Change | -40.70% |
| 5 Year Change | -10.53% |
| Change since IPO | -46.32% |
Recent News & Updates
Earnings Troubles May Signal Larger Issues for Thomson Medical Group (SGX:A50) Shareholders
Sep 02
Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)
Apr 01Recent updates
Earnings Troubles May Signal Larger Issues for Thomson Medical Group (SGX:A50) Shareholders
Sep 02Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)
Apr 01Should You Think About Buying Thomson Medical Group Limited (SGX:A50) Now?
Dec 16Here's Why Thomson Medical Group (SGX:A50) Has A Meaningful Debt Burden
Aug 31We Ran A Stock Scan For Earnings Growth And Thomson Medical Group (SGX:A50) Passed With Ease
Apr 24Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet
Mar 27Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet
Nov 22Should You Be Adding Thomson Medical Group (SGX:A50) To Your Watchlist Today?
Sep 30Market Participants Recognise Thomson Medical Group Limited's (SGX:A50) Earnings
Sep 03These 4 Measures Indicate That Thomson Medical Group (SGX:A50) Is Using Debt Reasonably Well
Feb 26We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt
Oct 21We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt
Mar 27Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)
Feb 20
Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?
Jan 27Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year
Dec 23Is Thomson Medical Group (SGX:A50) Using Too Much Debt?
Nov 27Shareholder Returns
| A50 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | 2.0% | -0.6% | 1.5% |
| 1Y | -15.0% | -22.0% | 3.3% |
Return vs Industry: A50 exceeded the SG Healthcare industry which returned -22% over the past year.
Return vs Market: A50 underperformed the SG Market which returned 3.3% over the past year.
Price Volatility
| A50 volatility | |
|---|---|
| A50 Average Weekly Movement | 3.4% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 14.8% |
| 10% least volatile stocks in SG Market | 2.4% |
Stable Share Price: A50 has not had significant price volatility in the past 3 months.
Volatility Over Time: A50's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 695 | Melvin Heng | www.thomsonmedical.com |
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore and Malaysia. It operates in Hospital Services and Specialised Services segments. The company owns and operates the Thomson Medical Centre, as well as a network of 37 clinics and centers that provide integrated medical healthcare facilities and services, such as obstetrics, gynaecology, paediatric, diagnostic imaging, pharmacy, 24-hour outpatient, laboratory, health screening, gynaecological oncology, dentistry, musculoskeletal and sports medicine, and medical aesthetics services, as well as counselling and specialised learning services for children with learning difficulties; and services provided by the fertility clinics, paediatric centres, cancer centres, cardiology centres, traditional Chinese medicine, specialist skin centre services.
Thomson Medical Group Limited Fundamentals Summary
| A50 fundamental statistics | |
|---|---|
| Market cap | S$1.35b |
| Earnings (TTM) | S$15.44m |
| Revenue (TTM) | S$382.65m |
87.4x
P/E Ratio3.5x
P/S RatioIs A50 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A50 income statement (TTM) | |
|---|---|
| Revenue | S$382.65m |
| Cost of Revenue | S$196.99m |
| Gross Profit | S$185.67m |
| Other Expenses | S$170.23m |
| Earnings | S$15.44m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00058 |
| Gross Margin | 48.52% |
| Net Profit Margin | 4.03% |
| Debt/Equity Ratio | 191.3% |
How did A50 perform over the long term?
See historical performance and comparison